BACKGROUND: We investigated the relationship between Aboriginality and 2-year cardiovascular disease outcomes in non-fatal first-ever myocardial infarction during 2000-04, with progressive adjustment of covariates, including comorbidities. DESIGN: Historical cohort study. METHODS: Person-linked hospital and mortality records were used to identify 28-day survivors of first-ever myocardial infarction in Western Australia during 2000-04 with 15-year lookback. The outcome measures were: (1) cardiovascular disease death; (2) recurrent admission for myocardial infarction; and (3) the composite of (1) and (2). RESULTS: Compared with non-Aboriginal patients, Aboriginals were younger and more likely to live remotely. The proportions having 5-year histories of diabetes and chronic kidney disease were double and triple those of non-Aboriginals. When adjusting for demographic variables alone, the Aboriginal to non-Aboriginal hazard ratios for cardiovascular death or recurrent myocardial infarction were 3.6 (95% CI 2.5-5.3) in men and 4.5 (95% CI 2.8-7.3) in women. After adjustment for comorbidities, including diabetes, chronic kidney disease and heart failure, the hazard ratios decreased 36% and 47% to 2.3 (1.6-3.0) and 2.4 (1.5-4.0) in males and females, respectively. CONCLUSIONS: The high prevalence of comorbidities in Aboriginal people, including diabetes, kidney disease, heart failure, and other risk factors contribute substantially to the disparity in post-myocardial infarction outcomes in Aboriginal people, reinforcing the importance of both primary prevention and comprehensive management of chronic conditions in this population. Aboriginality remains a significant independent risk factor for disease recurrence or mortality, even after adjusting for comorbidity, suggesting the need for society-level interventions addressing social disadvantage.
BACKGROUND: We investigated the relationship between Aboriginality and 2-year cardiovascular disease outcomes in non-fatal first-ever myocardial infarction during 2000-04, with progressive adjustment of covariates, including comorbidities. DESIGN: Historical cohort study. METHODS:Person-linked hospital and mortality records were used to identify 28-day survivors of first-ever myocardial infarction in Western Australia during 2000-04 with 15-year lookback. The outcome measures were: (1) cardiovascular disease death; (2) recurrent admission for myocardial infarction; and (3) the composite of (1) and (2). RESULTS: Compared with non-Aboriginal patients, Aboriginals were younger and more likely to live remotely. The proportions having 5-year histories of diabetes and chronic kidney disease were double and triple those of non-Aboriginals. When adjusting for demographic variables alone, the Aboriginal to non-Aboriginal hazard ratios for cardiovascular death or recurrent myocardial infarction were 3.6 (95% CI 2.5-5.3) in men and 4.5 (95% CI 2.8-7.3) in women. After adjustment for comorbidities, including diabetes, chronic kidney disease and heart failure, the hazard ratios decreased 36% and 47% to 2.3 (1.6-3.0) and 2.4 (1.5-4.0) in males and females, respectively. CONCLUSIONS: The high prevalence of comorbidities in Aboriginal people, including diabetes, kidney disease, heart failure, and other risk factors contribute substantially to the disparity in post-myocardial infarction outcomes in Aboriginal people, reinforcing the importance of both primary prevention and comprehensive management of chronic conditions in this population. Aboriginality remains a significant independent risk factor for disease recurrence or mortality, even after adjusting for comorbidity, suggesting the need for society-level interventions addressing social disadvantage.
Authors: Deborah A Randall; Louisa R Jorm; Sanja Lujic; Aiden J O'Loughlin; Timothy R Churches; Mary M Haines; Sandra J Eades; Alastair H Leyland Journal: BMC Public Health Date: 2012-04-10 Impact factor: 3.295
Authors: Lee Nedkoff; Matthew Knuiman; Joseph Hung; Frank M Sanfilippo; Judith M Katzenellenbogen; Tom G Briffa Journal: BMC Med Res Methodol Date: 2013-10-01 Impact factor: 4.615
Authors: Derrick Lopez; Judith M Katzenellenbogen; Frank M Sanfilippo; John A Woods; Michael S T Hobbs; Matthew W Knuiman; Tom G Briffa; Peter L Thompson; Sandra C Thompson Journal: Int J Equity Health Date: 2014-10-21
Authors: Lee Nedkoff; Matthew Knuiman; Michael S T Hobbs; Joseph Hung; Sushma Mathur; John Beilby; Anna Reynolds; Tom G Briffa; Derrick Lopez; Frank M Sanfilippo Journal: BMJ Open Date: 2016-08-24 Impact factor: 2.692
Authors: Sandra C Thompson; Emma Haynes; John A Woods; Dawn C Bessarab; Lynette A Dimer; Marianne M Wood; Frank M Sanfilippo; Sandra J Hamilton; Judith M Katzenellenbogen Journal: SAGE Open Med Date: 2016-11-29
Authors: John A Woods; Judith M Katzenellenbogen; Patricia M Davidson; Sandra C Thompson Journal: BMC Cardiovasc Disord Date: 2012-11-01 Impact factor: 2.298
Authors: Judith M Katzenellenbogen; Frank M Sanfilippo; Michael S T Hobbs; Matthew W Knuiman; Dawn Bessarab; Angela Durey; Sandra C Thompson Journal: BMC Health Serv Res Date: 2013-08-20 Impact factor: 2.655
Authors: Derrick Lopez; Judith M Katzenellenbogen; Frank M Sanfilippo; John A Woods; Michael S T Hobbs; Matthew W Knuiman; Tom G Briffa; Peter L Thompson; Sandra C Thompson Journal: BMC Cardiovasc Disord Date: 2014-05-01 Impact factor: 2.298
Authors: Pupalan Iyngkaran; Nadarajan Kangaharan; Hendrik Zimmet; Margaret Arstall; Rob Minson; Merlin C Thomas; Peter Bergin; John Atherton; Peter MacDonald; David L Hare; John D Horowitz; Marcus Ilton Journal: Curr Cardiol Rev Date: 2016
Authors: Pupalan Iyngkaran; Merlin C Thomas; Renee Johnson; John French; Marcus Ilton; Peter McDonald; David L Hare; Diane Fatkin Journal: Curr Cardiol Rev Date: 2016